Jens Hoffmann

Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system

Zoran Čulig, Jens Hoffmann, Martin Erdel et al. · British Journal of Cancer · 1999 · 419 citations · Full text

Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors

Moritz Schütte, Thomas S. Risch, Nilofar Abdavi-Azar et al. · Nature Communications · 2017 · 341 citations · Full text

Establishment of Patient-Derived Non–Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers

Iduna Fichtner, Jana Rolff, Richie Soong et al. · Clinical Cancer Research · 2008 · 282 citations · Full text

Regorafenib (BAY 73‐4506): Antitumor and antimetastatic activities in preclinical models of colorectal cancer

Roberta Schmieder, Jens Hoffmann, Michael W. Becker et al. · International Journal of Cancer · 2013 · 129 citations · Full text

Total Synthesis and Antitumor Activity of ZK‐EPO: The First Fully Synthetic Epothilone in Clinical Development

Ulrich Klar, Bernd Buchmann, Wolfgang Schwede et al. · Angewandte Chemie International Edition · 2006 · 125 citations

Medicinal Chemistry, Antitumor Activity, Second-generation Epothilones +12